U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT06931782) titled 'AI in Respiratory Disease Prevention, Diagnosis, and Triage' on March 26.
Brief Summary: This study will evaluate the impact of using the GPT-4o compared to traditional online tools in the field of respiratory disease prevention, focusing on the dissemination of knowledge and behavior changes among the general public. We will explore the effectiveness of GPT-4o in enhancing public awareness and management capabilities regarding respiratory diseases and promoting appropriate preventive behaviors.
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Respiratory Diseases
Artificial Intelligence (AI)
Randomized Controlle...